NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/18/2023
Back to search
Official data from USPTO
STARKAGE 5P
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STARKAGE 5P
ST13
US500000097328323Class
41, 42, 44
Filing
97328323
Registration
7030898
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
04/18/2023
Trademark type
Word
Nice classes
41, 42, 44
Filing date
03/24/2022
Registration date
04/18/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/18/2023
Last transaction
04/18/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Lille, FR
Examiner
EDWARDS, ALICIA
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. A. (pessoa física)
Representatives
PINA CAMPAGNA CARTER, DELUCA AND FARRELL LLP
Technical classification
Nice Classes
Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Medical training in aging and immunotherapy; Providing educational demonstrations in the field of aging and immunotherapy; Organization of educational eventsconferences and workshops in the field of aging and immunotherapy; Publishing of newspapers and magazinesrelated to the biotechnology sectorpublishing of electronic publications; Organization and conducting of symposiumsconferencescongresses and workshops in the field of biotechnology; Organization and conducting of symposiumsconferencescongresses and workshops in the field of aging and immunotherapy
Class 42
Biotechnological and pharmaceutical drug research and development services; Pharmaceutical and biotechnological research and development; Provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; Biologicalclinical and medical research in the field of aging and immunotherapy; Scientific research for medical purposes in the field of aging and immunotherapy; Computer-assisted scientific research services in the field of aging and immunotherapy; Scientific research information services in the field of aging and immunotherapy; Preparation of scientific research reports in the field of aging and immunotherapy; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Compiling data for research purposes in the field of medical science and medical consultancy
Class 44
Medical services; clinical medical consultation and analysis services; beauty care services
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/18/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/31/2023
PUBO
PUBLISHED FOR OPPOSITION
01/31/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/11/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
12/28/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
12/19/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/19/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
12/19/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/19/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2022
GNRT
NON-FINAL ACTION E-MAILED
06/02/2022
CNRT
NON-FINAL ACTION WRITTEN
06/02/2022
DOCK
ASSIGNED TO EXAMINER
05/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/29/2022
NWAP
NEW APPLICATION ENTERED
03/28/2022
Continuous trademark protection
Get notified about every new filing that threatens STARKAGE 5P or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.